Page 645 - Withrow and MacEwen's Small Animal Clinical Oncology, 6th Edition

CHAPTER 28 Tumors of the Mammary Gland 623

116. Szczubial M, Lopuszynski W: Prognostic value of regional lymph 136. Pena L, De Andres PJ, Clemente M, et al.: Prognostic value of his-
node status in canine mammary carcinomas, Vet Comp Oncol tological grading in noninflammatory canine mammary carcino-
9:296–303, 2011. mas in a prospective study with two-year follow-up: relationship
VetBooks.ir 117. Karayannopoulou M, Koutinas AF, Polizopoulou ZS, et al.: Total with clinical and histological characteristics, Vet Pathol 50:94–105,
2013.
serum alkaline phosphatase activity in dogs with mammary neo-
plasms: a prospective study on 79 natural cases, J Vet Med A Physiol
Pathol Clin Med 50:501–505, 2003. 137. Meuten DJ, Moore FM, George JW: Mitotic count and the field of
view area: time to standardize, Vet Pathol 53:7–9, 2016.
118. Karayannopoulou M, Polizopoulou ZS, Koutinas AF, et al.: Serum 138. Hellmen E, Bergstrom R, Holmberg L, et al.: Prognostic factors in
alkaline phosphatase isoenzyme activities in canine malignant canine mammary tumors: a multivariate study of 202 consecutive
mammary neoplasms with and without osseous transformation, cases, Vet Pathol 30:20–27, 1993.
Vet Clin Pathol 35:287–290, 2006. 139. Perez Alenza MD, Pena L, Nieto AI, et al.: Clinical and pathologi-
119. Cassali GD, Gobbi H, Malm C, et al.: Evaluation of accuracy of cal prognostic factors in canine mammary tumors, Ann Ist Super
fine needle aspiration cytology for diagnosis of canine mammary Sanita 33:581–585, 1997.
tumours: comparative features with human tumours, Cytopathology 140. MacEwen EG, Harvey HJ, Patnaik AK, et al.: Evaluation of effects
18:191–196, 2007. of levamisole and surgery on canine mammary cancer, J Biol
120. Simon D, Schoenrock D, Nolte I, et al.: Cytologic examination Response Mod 4:418–426, 1985.
of fine-needle aspirates from mammary gland tumors in the dog: 141. Philibert JC, Snyder PW, Glickman N, et al.: Influence of host fac-
diagnostic accuracy with comparison to histopathology and asso- tors on survival in dogs with malignant mammary gland tumors,
ciation with postoperative outcome, Vet Clin Pathol 38:521–528, J Vet Intern Med 17:102–106, 2003.
2009. 142. Morris JS, Dobson JM, Bostock DE: Use of tamoxifen in the con-
121. Eberle N, Fork M, von Babo V, et al.: Comparison of examina- trol of canine mammary neoplasia, Vet Rec 133:539–542, 1993.
tion of thoracic radiographs and thoracic computed tomography in 143. Chang SC, Chang CC, Chang TJ, et al.: Prognostic factors associ-
dogs with appendicular osteosarcoma, Vet Comp Oncol 9:131–140, ated with survival two years after surgery in dogs with malignant
2011. mammary tumors: 79 cases (1998–2002), J Am Vet Med Assoc
122. Otoni CC, Rahal SC, Vulcano LC, et al.: Survey radiography and 227:1625–1629, 2005.
computerized tomography imaging of the thorax in female dogs 144. de Araujo MR, Campos LC, Ferreira E, et al.: Quantitation of the
with mammary tumors, Acta Vet Scand 52:20, 2010. regional lymph node metastatic burden and prognosis in malig-
123. Lana SE, Rutteman GR, Withrow SJ: Tumors of the mammary nant mammary tumors of dogs, J Vet Intern Med 29:1360–1367,
gland. In Withrow SJ, Vail DM, editors: Withrow & MacEwen’s 2015.
small animal clinical oncology, ed 4, St. Louis, 2007, Saunders Else- 145. Stratmann N, Failing K, Richter A, et al.: Mammary tumor recur-
vier. rence in bitches after regional mastectomy, Vet Surg 37:82–86, 2008.
124. Owens L: Classification of tumors in domestic animals, ed 1, Geneva, 146. Horta RS, Figueiredo MS, Lavalle GE, et al.: Surgical stress and
1980, World Health Organization. postoperative complications related to regional and radical mastec-
125. Rutteman G, Withrow SJ, MacEwen EG: Tumors of the mammary tomy in dogs, Acta Vet Scand 57:34, 2015.
gland. In Withrow SJ, MacEwen EG, editors: Small animal clinical 147. Morris JS, Dobson JM, Bostock DE, et al.: Effect of ovariohysterec-
oncology, ed 3, Philadelphia, 2001, WB Saunders. tomy in bitches with mammary neoplasms, Vet Rec 142:656–658,
126. Sorenmo KU, Rasotto R, Zappulli V, et al.: Development, anat- 1998.
omy, histology, lymphatic drainage, clinical features, and cell differ- 148. Sorenmo KU, Shofer FS, Goldschmidt MH: Effect of spaying and
entiation markers of canine mammary gland neoplasms, Vet Pathol timing of spaying on survival of dogs with mammary carcinoma,
48:85–97, 2011. J Vet Intern Med 14:266–270, 2000.
127. Hampe JF, Misdorp W: Tumours and dysplasias of the mammary 149. Hermo GA, Torres P, Ripoll GV, et al.: Perioperative desmopressin
gland, Bull World Health Organ 50:111–133, 1974. prolongs survival in surgically treated bitches with mammary gland
128. Misdorp W, Else R, Hellmen E, et al.: Histological classification of tumours: a pilot study, Vet J 178:103–108, 2008.
mammary tumors of the dog and the cat, ed 2, Washington, DC, 150. Tran CM, Moore AS, Frimberger AE: Surgical treatment of mam-
1999, Armed Forces Institute of Pathology, pp 3–29. mary carcinomas in dogs with or without postoperative chemo-
129. Goldschmidt M, Pena L, Rasotto R, et al.: Classification and grad- therapy, Vet Comp Oncol 14:252–262, 2016.
ing of canine mammary tumors, Vet Pathol 48:117–131, 2011. 151. Rossi F, Sabattini S, Vascellari M, et al.: The impact of toceranib,
130. Rasotto R, Zappulli V, Castagnaro M, et al.: A retrospective study piroxicam and thalidomide with or without hypofractionated radi-
of those histopathologic parameters predictive of invasion of the ation therapy on clinical outcome in dogs with inflammatory mam-
lymphatic system by canine mammary carcinomas, Vet Pathol mary carcinoma, Vet Comp Oncol, 2018. https://doi.org/10.1111/
49:330–340, 2011. vco.12407. Epub ahead of print.
131. Rasotto R, Berlato D, Goldschmidt MH, et al.: Prognostic signifi- 152. Allen S, Mahaffey E: Canine mammary neoplasia: prognostic
cance of canine mammary tumor histologic subtypes: an observa- indicators and response to surgical therapy, J Am Anim Hosp Assoc
tional cohort study of 229 cases, Vet Pathol 54:571–578, 2017. 25:504–546, 1989.
132. Elston CW, Ellis IO: Pathological prognostic factors in breast 153. Tavares WL, Lavalle GE, Figueiredo MS, et al.: Evaluation of
cancer. I. The value of histological grade in breast cancer: experi- adverse effects in tamoxifen exposed healthy female dogs, Acta Vet
ence from a large study with long-term follow-up, Histopathology Scand 52:67, 2010.
19:403–410, 1991. 154. Guil-Luna S, Millan Y, De Andres J, et al.: Prognostic impact of
133. Misdorp W: Tumors of the mammary gland. In Meuten DJ, edi- neoadjuvant aglepristone treatment in clinicopathological param-
tor: Tumors in domestic animals, ed 4, Ames, Iowa, 2002, Iowa State eters of progesterone receptor-positive canine mammary carcino-
Press, pp 575–606, 764. mas, Vet Comp Oncol 15:391–399, 2017.
134. Clemente M, Perez-Alenza MD, Illera JC, et al.: Histological, 155. Yamagami T, Kobayashi T, Takahashi K, et al.: Influence of ovariec-
immunohistological, and ultrastructural description of vasculo- tomy at the time of mastectomy on the prognosis for canine malig-
genic mimicry in canine mammary cancer, Vet Pathol 47:265–274, nant mammary tumours, J Small Anim Pract 37:462–464, 1996.
2010. 156. Nabholtz JM, Senn HJ, Bezwoda WR, et al.: Prospective random-
135. Karayannopoulou M, Kaldrymidou E, Constantinidis TC, et al.: ized trial of docetaxel versus mitomycin plus vinblastine in patients
Histological grading and prognosis in dogs with mammary carci- with metastatic breast cancer progressing despite previous anthra-
nomas: application of a human grading method, J Comp Pathol cycline-containing chemotherapy. 304 study group, J Clin Oncol
133:246–252, 2005. 17:1413–1424, 1999.